
Quantum BioPharma's Third Debt Settlement in Two Years Points to a Pattern, Not a One-Off
QNTM's latest CAD$123,487 debt-for-equity swap is its third since 2024, while an FDA clinical hold on Lucid-MS and a 75% cash burn in six months compound the picture.









